论文部分内容阅读
阿霉素脂质体的Ⅲ期临床试验脂质体公司和辉瑞公司已开始了用脂质体阿霉素（ＴＬＣＫ－９９）治疗转移性乳房癌的二项Ⅲ期临床试验。一项试验是将该脂质体产品与阿霉素比较，另一项是将ＴＬＣ－９９和环磷酰胺联用并与阿霉素和环磷酰胺联用进行比较。阿霉素是最广泛使用的...
Phase III clinical trials of doxorubicin liposomes Liposomes and Pfizer have started phase II clinical trials of metastatic breast cancer with liposomal doxorubicin (TLCK-99). One trial compared the liposomal product to doxorubicin and the other compared TLC-99 with cyclophosphamide and compared with doxorubicin and cyclophosphamide. Adriamycin is the most widely used ...